Weekly vs. 3-weekly paclitaxel, carboplatin, and cetuximab (PCC) in recurrent/metastatic head and neck cancer.
Mol Clin Oncol. 2021 Nov;15(5):240. doi: 10.3892/mco.2021.2403. Epub 2021 Sep 22. Mol Clin Oncol. 2021. PMID: 34650807 Free PMC article.